GH Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities: | ||||||||||||||||||||||
net income | -114,985,000 | -187,043,000 | -86,102,000 | -72,771,000 | -133,533,000 | -139,934,000 | -161,994,000 | -229,432,000 | -123,228,000 | -72,311,000 | -107,526,000 | -97,575,000 | -107,358,000 | -93,045,000 | -71,670,000 | -49,739,000 | -31,829,000 | -22,110,000 | -13,090,000 | -11,300,000 | -21,351,000 | -25,272,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||
depreciation and amortization | 10,712,000 | 10,868,000 | 11,037,000 | 10,631,000 | 10,345,000 | 10,169,000 | 9,807,000 | 8,785,000 | 7,201,000 | 6,090,000 | 5,544,000 | 5,627,000 | 5,010,000 | 4,603,000 | 4,353,000 | 3,805,000 | 3,304,000 | 3,448,000 | 2,952,000 | 2,657,000 | 2,354,000 | 2,169,000 |
operating lease costs | 7,619,000 | 7,553,000 | 7,438,000 | 7,369,000 | 7,339,000 | |||||||||||||||||
stock-based compensation | 27,041,000 | 24,320,000 | 21,819,000 | 22,354,000 | 22,266,000 | |||||||||||||||||
amortization of debt issuance costs | 645,000 | 644,000 | 644,000 | 643,000 | 644,000 | 642,000 | 642,000 | 642,000 | 640,000 | 641,000 | 641,000 | |||||||||||
amortization of premium (discount) on marketable debt securities | 111,000 | 1,229,000 | ||||||||||||||||||||
unrealized losses (gains) on marketable equity securities | 30,054,000 | |||||||||||||||||||||
impairment of non-marketable equity securities and other related assets | 0 | 0 | ||||||||||||||||||||
other | 652,000 | -1,286,000 | 6,000 | 3,000 | -1,000 | 21,000 | ||||||||||||||||
cash effect of changes in operating assets and liabilities: | ||||||||||||||||||||||
accounts receivable | 4,220,000 | 18,000 | -2,335,000 | -1,654,000 | 12,349,000 | -11,056,000 | 9,076,000 | -10,944,000 | 13,299,000 | -36,908,000 | -7,077,000 | -5,628,000 | 5,260,000 | -17,044,000 | 4,687,000 | 7,073,000 | -179,000 | -8,297,000 | 674,000 | -11,374,000 | 11,608,000 | -21,050,000 |
inventory | -1,042,000 | 15,085,000 | -16,504,000 | -14,056,000 | 5,125,000 | 11,449,000 | -3,157,000 | -23,281,000 | -5,937,000 | -5,934,000 | 1,755,000 | 2,382,000 | -6,160,000 | 5,015,000 | -7,377,000 | 4,794,000 | -9,967,000 | -421,000 | -584,000 | -3,920,000 | -1,120,000 | -2,061,000 |
prepaid expenses and other current assets | -5,627,000 | -1,774,000 | -1,667,000 | 2,463,000 | -3,354,000 | -7,943,000 | 4,717,000 | 1,788,000 | 21,882,000 | -29,995,000 | -2,722,000 | -3,557,000 | 521,000 | -6,568,000 | 53,000 | 3,036,000 | -2,598,000 | -5,732,000 | -1,575,000 | 2,069,000 | -947,000 | -1,180,000 |
other assets | 1,024,000 | -982,000 | 580,000 | -65,000 | 1,765,000 | 6,928,000 | 469,000 | 455,000 | 3,846,000 | -956,000 | 1,056,000 | -5,484,000 | 1,202,000 | -11,755,000 | -7,329,000 | -403,000 | 161,000 | -1,809,000 | 86,000 | -296,000 | -833,000 | -548,000 |
accounts payable and accrued liabilities | 13,240,000 | 62,014,000 | 10,065,000 | 2,626,000 | 13,886,000 | |||||||||||||||||
operating lease liabilities | -8,835,000 | -8,754,000 | -7,754,000 | -7,548,000 | -7,422,000 | -7,235,000 | -6,398,000 | -3,489,000 | -3,106,000 | 13,947,000 | 3,291,000 | -271,000 | -2,762,000 | -2,519,000 | 358,000 | -2,023,000 | -1,858,000 | |||||
deferred revenue | 4,887,000 | -1,435,000 | 9,224,000 | -1,911,000 | -4,145,000 | 5,821,000 | -1,897,000 | 6,706,000 | -757,000 | 4,009,000 | -1,163,000 | 120,000 | -190,000 | 1,213,000 | -4,148,000 | -451,000 | -341,000 | -818,000 | -3,401,000 | -617,000 | 975,000 | 12,183,000 |
net cash from operating activities | -30,284,000 | -78,728,000 | -77,791,000 | -94,015,000 | -74,441,000 | -90,749,000 | -78,160,000 | -111,935,000 | -28,619,000 | -76,988,000 | -53,145,000 | -62,593,000 | -16,291,000 | -59,223,000 | -8,057,000 | -23,365,000 | -13,282,000 | -30,342,000 | 1,347,000 | -13,836,000 | -4,303,000 | -26,538,000 |
investing activities: | ||||||||||||||||||||||
purchase of marketable debt securities | 0 | -68,563,000 | -498,087,000 | -63,252,000 | -65,156,000 | |||||||||||||||||
maturity of marketable debt securities | 35,000,000 | 666,000,000 | 336,000,000 | 264,700,000 | 228,000,000 | 157,000,000 | ||||||||||||||||
purchase of property and equipment | -6,934,000 | -4,077,000 | -2,372,000 | -6,513,000 | -7,524,000 | -10,001,000 | -21,726,000 | -23,034,000 | -22,700,000 | -3,047,000 | -2,705,000 | -2,931,000 | ||||||||||
net cash from investing activities | 28,066,000 | 663,454,000 | 260,699,000 | -241,127,000 | 157,224,000 | 70,627,000 | 41,274,000 | -72,893,000 | 110,808,000 | -266,697,000 | -47,394,000 | 127,066,000 | 123,870,000 | -297,685,000 | -14,656,000 | -325,549,000 | 20,804,000 | 23,358,000 | -35,730,000 | -320,527,000 | 15,329,000 | -197,688,000 |
financing activities: | ||||||||||||||||||||||
proceeds from issuance of common stock upon exercise of stock options | 213,000 | 115,000 | 70,000 | 63,000 | 157,000 | 120,000 | 347,000 | 1,195,000 | 963,000 | 1,047,000 | 1,677,000 | 926,000 | 4,462,000 | 2,129,000 | 3,851,000 | 2,044,000 | 1,504,000 | 1,844,000 | 4,265,000 | 4,992,000 | 538,000 | 539,000 |
taxes paid related to net share settlement of restricted stock units | -1,544,000 | -3,085,000 | -3,003,000 | -4,116,000 | -993,000 | -1,359,000 | -4,340,000 | -1,222,000 | -957,000 | -1,602,000 | -7,199,000 | -1,382,000 | -73,576,000 | -1,200,000 | ||||||||
net cash from financing activities | -1,074,000 | 90,568,000 | 3,807,000 | 383,854,000 | -854,000 | 2,318,000 | -19,312,000 | -172,087,000 | -12,000 | 3,780,000 | -5,560,000 | 4,909,000 | -69,953,000 | 1,046,724,000 | 797,000 | 361,320,000 | 1,466,000 | 3,077,000 | 6,871,000 | 355,068,000 | 2,288,000 | 250,364,000 |
net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | -1,138,000 | 1,030,000 | -526,000 | -1,252,000 | -163,000 | 1,140,000 | -529,000 | -1,419,000 | -792,000 | -113,000 | 7,000 | -1,087,000 | ||||||||||
net increase in cash, cash equivalents and restricted cash | -4,430,000 | 676,324,000 | 186,189,000 | 47,460,000 | 81,766,000 | -16,664,000 | -56,727,000 | -358,334,000 | 81,385,000 | -340,405,000 | -106,212,000 | 69,389,000 | 36,539,000 | -3,960,000 | -27,465,000 | 20,864,000 | 13,245,000 | 26,165,000 | ||||
cash, cash equivalents and restricted cash—beginning of period | 1,133,687,000 | 0 | 141,948,000 | 0 | 0 | 492,288,000 | ||||||||||||||||
cash, cash equivalents and restricted cash—end of period | 1,129,257,000 | 47,460,000 | 223,714,000 | -56,727,000 | -358,334,000 | 573,673,000 | -106,212,000 | 69,389,000 | 869,516,000 | |||||||||||||
supplemental disclosures of noncash investing and financing activities: | ||||||||||||||||||||||
purchase of property and equipment included in accounts payable and accrued liabilities | 1,640,000 | |||||||||||||||||||||
reconciliation of cash, cash equivalents and restricted cash: | ||||||||||||||||||||||
cash and cash equivalents | 1,029,027,000 | -106,220,000 | ||||||||||||||||||||
restricted cash – included in cash, cash equivalents and restricted cash | 100,230,000 | |||||||||||||||||||||
total cash, cash equivalents and restricted cash | 1,129,257,000 | -106,212,000 | ||||||||||||||||||||
contingent consideration | -120,000 | 220,000 | 310,000 | -300,000 | ||||||||||||||||||
amortization of (discount) premium on marketable debt securities | -2,639,000 | -7,828,000 | -2,076,000 | -1,009,000 | ||||||||||||||||||
unrealized (gains) losses on marketable equity securities | 4,803,000 | |||||||||||||||||||||
fair value adjustments of noncontrolling interest liability | 0 | 0 | ||||||||||||||||||||
purchase of non-marketable equity securities and other related assets | 0 | -4,366,000 | ||||||||||||||||||||
proceeds from issuance of common stock under employee stock purchase plan | ||||||||||||||||||||||
proceeds from equity offerings | ||||||||||||||||||||||
payment of equity offering costs | ||||||||||||||||||||||
joint venture acquisition | 0 | 0 | ||||||||||||||||||||
tender offer issued in connection with the joint venture acquisition and acquisition related costs | 1,000 | |||||||||||||||||||||
cash, cash equivalents and restricted cash – beginning of period | ||||||||||||||||||||||
cash, cash equivalents and restricted cash – end of period | ||||||||||||||||||||||
supplemental disclosures of cash flow information: | ||||||||||||||||||||||
operating lease liabilities arising from obtaining right-of-use assets | 0 | 3,940,000 | 314,000 | 157,000 | 64,000 | 170,847,000 | ||||||||||||||||
reclassification of redeemable noncontrolling interest to noncontrolling interest liability | ||||||||||||||||||||||
restricted cash – included in other assets | 8,000 | |||||||||||||||||||||
proceeds from issuances of common stock under employee stock purchase plan | 0 | 0 | 0 | 0 | 3,185,000 | 0 | 1,933,000 | |||||||||||||||
proceeds from follow-on public offering | 0 | |||||||||||||||||||||
payment of offering costs related to follow-on public offering | 793,000 | |||||||||||||||||||||
unrealized gains on marketable equity securities | -63,997,000 | -3,882,000 | ||||||||||||||||||||
payments made on finance lease obligations | -19,000 | -18,000 | -18,000 | -18,000 | -17,000 | -18,000 | -17,000 | -38,000 | -36,000 | -55,000 | -49,000 | |||||||||||
impairment of non-marketable equity securities | 5,485,000 | |||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||
purchase of non-marketable equity securities and other related investments | 0 | |||||||||||||||||||||
non-cash operating lease costs | 7,191,000 | 7,197,000 | 7,248,000 | 6,949,000 | 6,879,000 | 6,943,000 | 6,907,000 | 3,932,000 | 2,218,000 | |||||||||||||
re-valuation of contingent consideration | 110,000 | 390,000 | 1,415,000 | 2,390,000 | 535,000 | 970,000 | 0 | 70,000 | 0 | -190,000 | ||||||||||||
non-cash stock-based compensation | 23,703,000 | 20,639,000 | 25,544,000 | 24,799,000 | 26,857,000 | 35,016,000 | 34,507,000 | 55,069,000 | 56,762,000 | 55,198,000 | 25,815,000 | 6,338,000 | 5,072,000 | 5,485,000 | 3,215,000 | 3,182,000 | 2,563,000 | |||||
amortization of debt discount and debt issuance costs | ||||||||||||||||||||||
unrealized losses on marketable equity securities | -5,437,000 | |||||||||||||||||||||
impairment of other assets | 0 | |||||||||||||||||||||
credit loss adjustment and others | 39,000 | -905,000 | ||||||||||||||||||||
payment of contingent consideration | 0 | |||||||||||||||||||||
proceeds from public offerings of common stock | ||||||||||||||||||||||
payment of offering costs related to public offerings of common stock | ||||||||||||||||||||||
proceeds from borrowings on convertible senior notes | ||||||||||||||||||||||
payment of offering costs related to borrowings on convertible senior notes | 0 | 0 | 0 | -784,000 | ||||||||||||||||||
purchase of convertible note hedges | ||||||||||||||||||||||
property and equipment acquired under finance leases | 0 | 2,000 | ||||||||||||||||||||
vesting of common stock exercised early | ||||||||||||||||||||||
debt issuance costs included in accounts payable and accrued liabilities | ||||||||||||||||||||||
accounts payable | 6,663,000 | 11,842,000 | -753,000 | 1,699,000 | -173,000 | -4,874,000 | 11,986,000 | -8,705,000 | 3,322,000 | -11,967,000 | 9,491,000 | 3,915,000 | -2,987,000 | 6,023,000 | -2,610,000 | 1,698,000 | ||||||
accrued compensation | 18,751,000 | -17,486,000 | 13,662,000 | 3,658,000 | 4,103,000 | -2,445,000 | 8,900,000 | 4,243,000 | 5,511,000 | -4,409,000 | 4,378,000 | -6,047,000 | 10,917,000 | -996,000 | 1,697,000 | 5,556,000 | ||||||
accrued expenses and other liabilities | -1,125,000 | 7,137,000 | 8,022,000 | 3,180,000 | 2,905,000 | 4,399,000 | 306,000 | 3,429,000 | ||||||||||||||
purchase of property and equipment included in accounts payable and accrued expenses | ||||||||||||||||||||||
issuance costs related to purchase of non-marketable equity and other related investments included in accounts payable and accrued expenses | -241,000 | |||||||||||||||||||||
amortization of premium (discount) on marketable securities | 1,351,000 | 2,449,000 | 3,303,000 | 3,018,000 | 3,269,000 | 3,259,000 | 2,380,000 | 571,000 | 485,000 | 580,000 | ||||||||||||
purchase of marketable securities | -74,859,000 | -163,742,000 | -372,875,000 | -45,966,000 | -238,757,000 | |||||||||||||||||
maturity of marketable securities | 25,000,000 | 310,000,000 | 325,000,000 | 209,000,000 | 214,000,000 | 204,110,000 | 255,000,000 | 110,000,000 | 93,500,000 | 104,048,000 | 102,269,000 | 93,904,000 | 65,160,000 | 64,000,000 | 44,000,000 | |||||||
purchase of non-marketable equity and other related investments | -12,750,000 | -346,000 | -26,326,000 | |||||||||||||||||||
benefit from income tax differences | ||||||||||||||||||||||
changes in operating assets and liabilities, net of effect of acquisition: | ||||||||||||||||||||||
payment in connection with a license agreement | ||||||||||||||||||||||
purchases of property and equipment included in accounts payable and accrued expenses | -697,000 | -700,000 | 2,544,000 | |||||||||||||||||||
debt issuance costs included in accounts payable and accrued expenses | ||||||||||||||||||||||
purchases of marketable securities | -207,919,000 | -55,509,000 | -70,654,000 | -114,870,000 | -409,542,000 | -55,760,000 | ||||||||||||||||
purchases of property and equipment | -22,149,000 | -18,675,000 | -9,586,000 | -9,786,000 | -9,507,000 | -9,598,000 | ||||||||||||||||
cash and cash equivalents—beginning of period | 0 | 0 | 832,977,000 | |||||||||||||||||||
follow-on public offering issuance costs included in accounts payable and accrued expenses | ||||||||||||||||||||||
cash and cash equivalents – end of period | ||||||||||||||||||||||
deferred offering costs included in accounts payable and accrued expenses | ||||||||||||||||||||||
conversion of convertible preferred stock to common stock upon initial public offering | ||||||||||||||||||||||
cash and cash equivalents—end of period | ||||||||||||||||||||||
amortization of rou | ||||||||||||||||||||||
loss on debt extinguishment | ||||||||||||||||||||||
long-term operating lease liabilities net of rou | ||||||||||||||||||||||
payment related to settlement of debt and buyout of royalty obligations | ||||||||||||||||||||||
proceeds from issuance of convertible preferred stock, net of issuance costs | ||||||||||||||||||||||
repurchase of convertible preferred stock | ||||||||||||||||||||||
capitalized license fees financed through future royalty payment | ||||||||||||||||||||||
issuance of series d convertible preferred stock in exchange for a technology license agreement | ||||||||||||||||||||||
increase in purchases of property and equipment included in accounts payable and accrued expenses | ||||||||||||||||||||||
property and equipment acquired under capital leases | ||||||||||||||||||||||
benefit from income taxes | ||||||||||||||||||||||
purchases of intangible assets and capitalized license obligations | ||||||||||||||||||||||
deferred tax assets | ||||||||||||||||||||||
business acquisitions, net of cash acquired | ||||||||||||||||||||||
proceeds from initial public offering, net of underwriting discounts and commissions | ||||||||||||||||||||||
unrealized translation losses on obligation related to royalty | ||||||||||||||||||||||
amortization of premium or discounts on marketable securities |